Pediatric drugs in China: Problems and countermeasures / 国际药学研究杂志

ABSTRACT

Taking the differences between the pediatric drugs and adult drugs as the starting-point, this article analyzes the main problems of the pediatric drugs in China, such as the shortage of the pediatric drugs. The causes of the problems mainly include high research and development cost of the pediatric drugs, their limited market capacity, difficulty in recruiting trial participants, the less clinical trial institutions in pediatrics, and governments’ incentive polices on research and development of pediatric drugs did not really play their roles. The countermeasures to solve these problems mainly include introducing relevant policy to guarantee the research and development companies’ profit, selecting appropriate varieties of the pediatric drugs to research and develop, promoting the establishment of pediatric clinical trial institutions as soon as possible, and establishing particular passage for pediatric drugs approval, in order to provide references for the government when making policies on pediatric drugs.